Claudio Dansky Ullmann
Contextual Change (United States)(US)
Publications by Year
Research Areas
Microtubule and mitosis dynamics, Immunotherapy and Immune Responses, Cancer-related Molecular Pathways, Cancer Treatment and Pharmacology, Lung Cancer Research Studies
Most-Cited Works
- → Head and neck squamous cell cancer and the human papillomavirus: Summary of a National Cancer Institute State of the Science Meeting, November 9–10, 2008, Washington, D.C.(2009)262 cited
- → Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study(2015)250 cited
- → Randomized Phase III Study of Alisertib or Investigator’s Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma(2019)145 cited
- → Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses(2019)144 cited
- → Transoral resection of pharyngeal cancer: Summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6–7, 2011, Arlington, Virginia(2012)102 cited
- Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (131I-CC49) when given in combination with gamma-interferon.(1993)
- → Initial results from first-in-human study of IPI-549, a tumor macrophage-targeting agent, combined with nivolumab in advanced solid tumors.(2018)55 cited
- → A population‐based study of therapy and survival for patients with head and neck cancer treated in the community(2012)54 cited
- → Targeting embryonic signaling pathways in cancer therapy(2012)39 cited
- Flavopiridol-related proinflammatory syndrome is associated with induction of interleukin-6.(2003)